Open original FDA record ↗Recall record
- FDA identifier
- Z-1079-2016
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc
- FDA classification date
- Mar 8, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
ADVIA Centaur Systems Calibrator E Lot 42 and 43 Bias with the Testosterone Assay
Source facts
- Action
- Siemens Healthcare issued an Urgent Medical Device Correction (UMDC) to all affected Siemens Healthcare Diagnostics customers in the United States on February 4, 2016 to be delivered to customers on February 5, 2016. An Urgent Field Safety Notice (UFSN) was sent out for distribution to customers outside the United States on February 4, 2016. These notices inform the customers of the lot to lot bias of Calibrator E with the ADVIA Centaur Testosterone assay and advise customers to move to Calibrator E kit lots ending in 44. Fax-back forms will be used to confirm that the customers received the Urgent Medical Device Correction. Questions, contact your Siemens Customer Care Center or your local Siemens technical support representative
- Initiated
- 2016-02-04
- Root cause
- Under Investigation by firm
- Terminated
- 2017-08-01
- Distribution
- Worldwide Distribution US (nationwide) and Internationally to: Canada AR AU BD BR CA CH CL CN CO DO EC GT HK ID IE IL IN JP KR LK MM MX MY NI NP NZ PE PH PY SA SG TH TW UY VN ZA
- Recall number
- Z-1079-2016
- Recall status
- Terminated
- CDRH record ID
- 143654
- FDA classified
- 2016-03-08
- Recall event number
- 73263